Specialists in antibody reagents, kits and services. Adding value through annotation, validation, sequencing, engineering and recombinant manufacturing.
Joined August 2022
- Tweets190
- Following142
- Followers51
- Likes64
Pinned Tweet
We’re thrilled to merge with Vector Laboratories! This partnership will enhance our offerings and drive innovation in antibody solutions for the life sciences community. Stay tuned for more updates.
Vector Laboratories today announced its intention to merge with @AbsoluteBiotech, a unified company of multiple antibody-centric brands. The transaction is a milestone in our commitment to better serve life science customers.
Read the full release: bit.ly/3QLfcRS
In this recent Nature article, MC-38 murine colon adenocarcinoma cells from Kerafast were used as in vivo mouse tumor models and to create a dendritic cell (DC) vaccine against cancer.
Study: nature.com/articles/s41467-0…
MC-38: kerafast.com/productgroup/66…
This 2024 study used @AbsAntibody's anti-TIGIT 1B4 to find that combination therapy targeting TIGIT and Tregs was effective at slowing ovarian cancer, the deadliest gynecological cancer. Full study: tinyurl.com/5efe7vsr
From smallpox inoculations in 1715 to the FDA approving it’s 100th monoclonal antibody in 2021, the advances in science and healthcare made possible by antibodies are truly remarkable. See more milestones in @AbsAntibody's History of Antibodies poster: bit.ly/4jaqyeR
Achieve confidence in your WB results with positive control lysates specific to Everest’s purified goat polyclonal antibody batches.
Positive control lysates here: everestbiotech.com/category/…
The newest @AbsAntibody blog post discusses recombinant antibody technology and how it is contributing to the fight against antimicrobial resistance. Read the blog: tinyurl.com/ykrbwkn6
Antimicrobial resistance is on the rise and is estimated to reach $1 trillion USD in additional healthcare costs by the year 2050. One solution being explored for this public health crisis is the use of antibodies as antibacterial agents. Learn more: tinyurl.com/ykrbwkn6
Our new article highlights the mechanisms of antibody-mediated cell depletion and how it revolutionizes cancer and autoimmune disease treatment.
Read the article here: absoluteantibody.com/general…
#AntibodyTherapeutics
Our team, Catherine Bladen PhD and Alex Scott, will be at #PEGSEurope next week in Barcelona, Spain. We invite you to visit us at booth #1310 to learn more about our custom services and explore our extensive antibody reagent catalog.
DON’T MISS OUT: Join @AbsAntibody and Dr. Lucia Lupica Spagnolo tomorrow as we discuss the process of humanizing antibodies from murine and non-murine origins. Register here: bit.ly/3XOOls5
Recent citations of Kerafast cell lines study the effect of dietary probiotics on cancer therapy, how fight or flight mode impacts tumors, and more.
Read more: ow.ly/nBMi50Tvuup
Absolute Biotech retweeted
Join us Oct. 2 for a live webinar with Dr. Lucia Lupica-Spagnolo as she discusses the Prometheus 2.0™ antibody humanization platform and how it has been optimized to increase expression titers and decrease aggregation of humanized antibodies: bit.ly/3XOOls5
Mpox has been declared a public health emergency. Recombinant engineered antibodies can help develop better vaccines and diagnostics. #Mpox
Read more here: absoluteantibody.com/general…
Exciting times ahead at ADLM 2024! Visit us at booth #1245 next week to learn more about how our custom sequencing, engineering, and bulk antibody production services. #ADLM2024
Product Development Manager Jane Shatford offers western blotting tips in this new article: ow.ly/Ij4g50SFvob
Every Everest antibody includes WB validation data: ow.ly/na3F50SFvoa
From the first smallpox inoculations to the 100th FDA approved monoclonal antibody, check out our full “History of Antibodies” poster for interesting and noteworthy antibody milestones. ow.ly/YBvH50RSskN
We’re at PEGS Boston this week. Visit us at booth #312.
Our Chief Operating Officer Dr. Catherine Bladen and VP of Channel Sales Andrew Elston are onsite and ready to discuss the latest in recombinant antibody technology. #PEGSBoston2024 #PEGSBoston
Join us at booth #312 during PEGS Boston next week to discover our comprehensive antibody sequencing, engineering, and recombinant expression services, along with an extensive range of antibody reagents. #PEGSBoston2024 #PEGSBoston
The advancements made to our Prometheus 2.0™ humanization platform have allowed us to expand our services to include humanizing antibodies from non-murine origin species. Watch the short video below for more information: ow.ly/eZrn50RuOze
Our CSO Frans Ramaekers was featured in this new article highlighting advancements in cell cycle research tools. FIX&PERM is one of those tools that open up (literally) cellular interiors for flow cytometry. Full article here: ow.ly/eM6250Rihp1
New research! Skin biopsies can be used to detect a key protein for Parkinson’s disease.
Our recombinant neuroscience antibodies: ow.ly/PFa550RbPRy
Study link: ow.ly/PFa550RbPRy
